Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Gemfibrozil
Sandoz Pty Ltd
Medicine Registered
_Product Information _ _Page 1 _ _Gemhexal 600mg Film-Coated Tablets _ _02/2013_ _Sandoz Pty Ltd _ _ _ _ _ PRODUCT INFORMATION GEMHEXAL 600MG FILM-COATED TABLETS NAME OF THE MEDICINE Generic name: Gemfibrozil _ _ Chemical name:_ 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid _ CAS [25812-30-0] Empirical formula: C 15 H 22 O 3 MW: 250.35 DESCRIPTION Gemfibrozil is a nonhalogenated phenoxypentanoic acid. It is a white, waxy powder which is stable under ordinary conditions. The melting point is 58-61ºC. Its solubility is 0.0019% (w/v) in water and in acid, and over 1% in dilute base. Gemhexal tablets also contain as inactive ingredients: lactose, microcrystalline cellulose, maize starch, hydroxypropyl cellulose, sodium starch glycollate, magnesium stearate, polysorbate 80, colloidal anhydrous silica, hypromellose, titanium dioxide, macrogol 4000. PHARMACOLOGY Pharmacodynamics Gemfibrozil is a lipid regulating agent which decreases serum triglycerides and total cholesterol, and increases high density lipoprotein cholesterol (HDL cholesterol). The lipid lowering changes occur primarily in the very low density lipoprotein (VLDL) fraction rich in triglycerides and to a lesser extent in the low density lipoprotein (LDL) fraction rich in cholesterol. Gemfibrozil treatment of patients with elevated triglycerides due to type IV hyperlipoproteinaemia may cause a rise in LDL cholesterol. However, Gemfibrozil increases the HDL cholesterol subfractions HDL 2 and HDL 3 , as well as apolipoproteins AI and AII. Its mechanism of action has not been definitely established in humans. Gemf Read the complete document